New Fed Chair, Rising Rate Hike Odds, and a Market That’s Still Near All-Time Highs — Something Has to Give
Kevin Warsh just replaced Jerome Powell. Inflation is at 3.8%. The FedWatch Tool is pricing in rate hikes, not cuts.…
Kevin Warsh just replaced Jerome Powell. Inflation is at 3.8%. The FedWatch Tool is pricing in rate hikes, not cuts.…
Defense budgets are hitting records. Backlogs are at all-time highs. And U.S. defense names still trade at a discount to…
Record revenue, record EBITDA, record units. The market still isn't sure what to do with CVNA.
NVDA just delivered $81.6B in revenue and record net income. The post-earnings drift tells a more complicated story.
MU just reported $23.86B in quarterly revenue — up nearly 3x year-over-year. Here's why the real story is still being…
Mounjaro up 125%. Zepbound up 79%. A new oral pill just launched. The growth story keeps widening.
A single analyst call rewired how Wall Street thinks about memory chips — and MU hasn't looked back.
Eli Lilly's Q1 blowout reset the ceiling — and the options flow is telling a very specific story
Custom silicon, record revenue, and a $100B runway — this is not your average chip story.
The biggest put buying eruption in TLT in recent memory just happened. This is not a drill.